All Companies
🇬🇧

Juvenescence

Private

Multi-approach anti-aging therapeutics

Juvenescence is a longevity-focused biotech exploring multiple approaches to combat age-related diseases, including small molecules, gene therapies, and regenerative medicine. The company has subsidiaries working on senolytics, metabolic health, and AI-driven drug discovery for aging.

Founded2017
HQLondon, United Kingdom
CEOGreg Bailey
StatusPrivate
Total Funding$250M

Pipeline

Drug / ProgramIndicationPhaseTechnology
Metabolic health programMetabolic diseases of agingPhase 1Small molecule

Key People

Greg BaileyCEO & Co-founder